MDSCs were also reported to promote immune evasion in melanoma cells by inhibiting T cell activity and macrophage-mediated phagocytosis [227,285,286] and to confer stemness properties to tumor cells by activating the IL-6/STAT3 signaling pathway [287]. The gene discussed is STAT3; the disease is melanoma.